Monday, August 31, 2026

PACCAR Stock Bearish By 28% In The Last 21 Sessions

ViaNews Editorial Team

February 10, 2023

PACCAR Stock Bearish By 28% In The Last 21 Sessions

(VIANEWS) - Shares of PACCAR (NASDAQ: PCAR) fell by a staggering 28.09% in 21 sessions from $101.06 at 2023-01-11, to $72.67 at 12:44 EST on Friday, following the last session's upward trend. NASDAQ is falling 1.23% to $11,644.80, after two successive sessions in a row of losses.

PACCAR's last close was $73.01, 35.33% below its 52-week high of $112.89.

About PACCAR

PACCAR Inc designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks in the United States, Europe, Mexico, South America, Australia, and internationally. It operates through three segments: Truck, Parts, and Financial Services. The Truck segment designs, manufactures, and distributes trucks for the over-the-road and off-highway hauling of commercial and consumer goods. It sells its trucks through a network of independent dealers under the Kenworth, Peterbilt, and DAF nameplates. The Parts segment distributes aftermarket parts for trucks and related commercial vehicles. The Financial Services segment conducts full-service leasing operations under the PacLease trade name, as well as provides finance and leasing products and services to customers and dealers. This segment also offers equipment financing and administrative support services for its franchisees; retail loan and leasing services for small, medium, and large commercial trucking companies, as well as independent owners/operators and other businesses; and truck inventory financing services to independent dealers. In addition, this segment offers loans and leases directly to customers for the acquisition of trucks and related equipment. The company also manufactures and markets industrial winches under the Braden, Carco, and Gearmatic nameplates. PACCAR Inc was founded in 1905 and is headquartered in Bellevue, Washington.

Earnings Per Share

As for profitability, PACCAR has a trailing twelve months EPS of $4.06.

PE Ratio

PACCAR has a trailing twelve months price to earnings ratio of 17.89. Meaning, the purchaser of the share is investing $17.89 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.43%.

Volume

Today's last reported volume for PACCAR is 802188 which is 77.05% below its average volume of 3340970.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Nov 13, 2022, the estimated forward annual dividend rate is 1.48 and the estimated forward annual dividend yield is 1.59%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 37.2%, now sitting on 27.38B for the twelve trailing months.

Volatility

PACCAR's last week, last month's, and last quarter's current intraday variation average was a negative 0.40%, a positive 0.52%, and a positive 1.10%.

PACCAR's highest amplitude of average volatility was 0.56% (last week), 1.47% (last month), and 1.10% (last quarter).

More news about PACCAR (PCAR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com